This week: A frostbitten cat gets 3D-printed paws, a con man peddling canine-cancer cures gets caught, and a veterinary school that admits rejected candidates . . . for a price.
The opioid shortage isn’t going away any time soon. The shortage, which is severely affecting veterinarians’ ability to provide pain management for patients, is expected to last into 2019. The primary short-term cause is a production issue at a Pfizer, Inc. plant in Kansas, but residual hurricane damage in Puerto Rico, a major pharmaceutical manufacturing center, and a pre-existing Drug Enforcement Agency mandate to reduce the manufacture of opioid medication in the United States by 20% in 2018, are also having an effect.
This week: checking for microchips becomes law in New York, why more dogs aren't sniffing out cancer, and nipping compassion fatigue in the bud